v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jan. 02, 2026
Jan. 03, 2025
Cash Flows From Operating Activities    
Net loss $ (25,425) $ (124,748)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 5,237 6,130
Depreciation and amortization 12,998 15,132
Equity in (earnings) loss of unconsolidated joint ventures (1,508) 4,728
Return on investments in unconsolidated joint ventures 6,374 694
ERP pre-implementation asset impairment 0 10,428
Gain on sale of assets (75) (20,725)
Other, net 3,605 3,858
Changes in operating assets and liabilities:    
Accounts receivable, net 12,809 11,190
Contract assets (40,156) 104,139
Accounts payable 23,067 (35,114)
Contract liabilities (48,764) (13,260)
Accrued expenses (4,384) 9,940
Other assets and liabilities (8,892) 6,349
Net cash used in operating activities (65,114) (21,259)
Cash Flows From Investing Activities    
Purchases of property, plant and equipment (6,371) (10,477)
Proceeds from sale of assets 4,872 31,774
Unconsolidated joint venture equity contributions (189) (6,460)
Return of investments in unconsolidated joint ventures 2,812 204
Net cash provided by investing activities 1,124 15,041
Cash Flows From Financing Activities    
Borrowings on credit and loan agreements 129,463 9,496
Repayments on credit and loan agreements (75,273) 0
Net repayments of Revolving Credit Facility 0 (29,915)
Other, net (4,136) (1,478)
Net cash provided by (used in) financing activities 50,054 (21,897)
Net (decrease) increase in cash, cash equivalents and restricted cash (13,936) (28,115)
Cash, cash equivalents and restricted cash, beginning of period 35,795 63,910
Cash, cash equivalents and restricted cash, end of period 21,859 35,795
Reconciliation of cash, cash equivalents and restricted cash to the Consolidated Balance Sheets    
Cash and cash equivalents 19,969 33,730
Restricted cash 1,890 2,065
Total cash, cash equivalents and restricted cash $ 21,859 $ 35,795